This Recovering Opioid User Worries that the GOP Health Bill Will Be Her Death Sentence

Meet Shelby.

On Tuesday morning, Senate Democrats blasted the draconian cuts to Medicaid proposed by the Senate health bill, highlighting the spiraling opioid epidemic taking hold across the country. The bill would cut an estimated $772 billion over ten years from Medicaid, the country’s leading payer for addiction treatment. (For more of what the Senate bill would mean for the opioid epidemic, check out our explainer.)

Among the participants in the Dems’ D.C.  press conference was a woman from West Virginia named Shelby, who, like thousands of others, depends on Medicaid for opioid addiction medication. 

“Without Medicaid, I wouldn’t have a family. Without Medicaid, I’d be dead,” she said. Shelby used opioids “from the street” for three years until she began a treatment program funded by Medicaid. “It was like someone handing their hand out to me and pulling me out of the hole,” Shelby said. “If this bill goes through,” she explained through tears, “the next time you might see my name in any paper might be in the obituary.” 

FACT:

Mother Jones was founded as a nonprofit in 1976 because we knew corporations and the wealthy wouldn't fund the type of hard-hitting journalism we set out to do.

Today, reader support makes up about two-thirds of our budget, allows us to dig deep on stories that matter, and lets us keep our reporting free for everyone. If you value what you get from Mother Jones, please join us with a tax-deductible donation today so we can keep on doing the type of journalism 2019 demands.

We Recommend

Latest

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate

We have a new comment system! We are now using Coral, from Vox Media, for comments on all new articles. We'd love your feedback.